Effects of inhibitors for CaM and CaN in fast and slow endocytosis at P7–9 calyces. (a) Top, Cm changes induced by a stimulus train (20 pulses of 20-ms depolarization at 1 Hz) in the terminal preloaded with control peptide (0.2 μM, black, P8), MLCK peptide (0.2 μM, red, P8), CBD peptide (20 μM, dark gray, P8) or MLCK peptide (0.2 μM) and 10 mM EGTA (blue, P9). Bottom, averaged Cm records, shown at a slow time scale, from P7–9 calyceal terminals (n = 5 for each). Data from terminals preloaded with 10 mM EGTA () were superimposed (dashed orange line) on data from terminals preloaded with 10 mM EGTA and MLCK peptide (blue) in the bottom right panel. Gray shading indicates s.e.m. Black bars indicate the period of stimulation. (b) Summary data for the Cm decay rate (ordinate) measured after each pulse during the 1-Hz train versus stimulus number (abscissa) in the presence of control peptide (black, n = 6), MLCK peptide (red, n = 6), CBD peptide (dark gray, n = 5) or MLCK peptide and 10 mM EGTA (blue, n = 6). Dashed line indicates data from 10 mM EGTA-loaded terminals (). (c) Averaged Cm traces shown in a normalized at the peak (superimposed). (d–f) Data are presented as in a–c for terminals loaded with 0.1% DMSO (black) or calyceal terminals loaded with FK-506 (0.1 μM, with 0.1% DMSO, red), cyclosporin A (CysA, 1 μM, with 0.1% DMSO, dark gray) or FK-506 and MLCK peptide (0.2 μM, blue) in P7–9 rats. Sample records (top panels of d) were derived from different calyceal terminals in P8 rats. Averaged Cm records (bottom panels of d) were obtained from 6–11 terminals. Error bars represent s.e.m.